Joela Mathews

408 total citations
21 papers, 220 citations indexed

About

Joela Mathews is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Joela Mathews has authored 21 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in Joela Mathews's work include Chronic Lymphocytic Leukemia Research (8 papers), Multiple Sclerosis Research Studies (8 papers) and Polyomavirus and related diseases (6 papers). Joela Mathews is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Multiple Sclerosis Research Studies (8 papers) and Polyomavirus and related diseases (6 papers). Joela Mathews collaborates with scholars based in United Kingdom, Spain and United States. Joela Mathews's co-authors include Gavin Giovannoni, Klaus Schmierer, Benjamin Turner, David Baker, Saúl Reyes, Mónica Marta, Sharmilee Gnanapavan, Ruth Dobson, César Álvarez-González and Mary Ramsay and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and Journal of Neuroimmunology.

In The Last Decade

Joela Mathews

17 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joela Mathews United Kingdom 8 164 59 53 50 37 21 220
Erin Coughlin United States 8 52 0.3× 86 1.5× 30 0.6× 41 0.8× 55 1.5× 15 283
Gustavo Luna United States 3 272 1.7× 88 1.5× 149 2.8× 112 2.2× 18 0.5× 4 363
Ian Gabriel United Kingdom 6 81 0.5× 96 1.6× 23 0.4× 16 0.3× 12 0.3× 15 172
Teresa Olivé Spain 9 39 0.2× 40 0.7× 32 0.6× 20 0.4× 89 2.4× 16 301
Licínio Craveiro Switzerland 8 187 1.1× 61 1.0× 98 1.8× 49 1.0× 21 0.6× 27 258
Caroline Bensa France 4 182 1.1× 44 0.7× 126 2.4× 59 1.2× 8 0.2× 8 230
Nada Abou-Fayssal United States 5 122 0.7× 55 0.9× 119 2.2× 89 1.8× 16 0.4× 7 247
Lawrence Kaplan United States 8 50 0.3× 73 1.2× 14 0.3× 18 0.4× 45 1.2× 14 195
Maurice Dahdaleh Saudi Arabia 11 230 1.4× 55 0.9× 70 1.3× 28 0.6× 31 0.8× 16 285
Adir Shaulov Israel 11 36 0.2× 110 1.9× 35 0.7× 18 0.4× 102 2.8× 50 299

Countries citing papers authored by Joela Mathews

Since Specialization
Citations

This map shows the geographic impact of Joela Mathews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joela Mathews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joela Mathews more than expected).

Fields of papers citing papers by Joela Mathews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joela Mathews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joela Mathews. The network helps show where Joela Mathews may publish in the future.

Co-authorship network of co-authors of Joela Mathews

This figure shows the co-authorship network connecting the top 25 collaborators of Joela Mathews. A scholar is included among the top collaborators of Joela Mathews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joela Mathews. Joela Mathews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varley, James, Rahma Beyrouti, Richard Nicholas, et al.. (2025). A comparison of JC virus assay performance provided with originator and biosimilar natalizumab. Multiple Sclerosis Journal. 31(7). 882–885.
2.
Henshall, David, Daoud Chaudhry, Setthasorn Zhi Yang Ooi, et al.. (2024). Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland. BMC Neurology. 24(1). 105–105. 2 indexed citations
3.
MacDougall, Amy, Ashok Adams, Lucia Bianchi, et al.. (2023). Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders. 16. 4223481715–4223481715. 5 indexed citations
4.
Dobson, Ruth, David Rog, Caroline Ovadia, et al.. (2022). Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines. Practical Neurology. 23(1). 6–14. 24 indexed citations
5.
Giovannoni, Gavin & Joela Mathews. (2022). Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review. Neurology and Therapy. 11(2). 571–595. 40 indexed citations
6.
Rog, David, et al.. (2022). 107  The UK multiple sclerosis service and DMT prescribing audit of 70 centres: overview. Journal of Neurology Neurosurgery & Psychiatry. 93(6). A134.2–A134. 1 indexed citations
7.
Mathews, Joela, et al.. (2022). 159 The growing role of the neuropharmacist: helping to deal with staff shortages in other professions. Journal of Neurology Neurosurgery & Psychiatry. 93(9). e2.117–e2.117.
8.
Reyes, Saúl, Anthony L. Cunningham, Tomáš Kalinčík, et al.. (2021). Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement. Journal of Neuroimmunology. 357. 577627–577627. 32 indexed citations
9.
Reyes, Saúl, Mary Ramsay, Shamez Ladhani, et al.. (2020). Protecting people with multiple sclerosis through vaccination. Practical Neurology. 20(6). 435.1–445. 36 indexed citations
10.
Reyes, Saúl, Sebastián Suárez, Özlem Kayım Yıldız, et al.. (2020). Socioeconomic status and disease-modifying therapy prescribing patterns in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 41. 102024–102024. 6 indexed citations
11.
Reyes, Saúl, et al.. (2020). Severe skin reactions associated with cladribine in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 43. 102140–102140. 4 indexed citations
12.
Reyes, Saúl, Benjamin Turner, Joela Mathews, et al.. (2019). Severe skin reactions associated with Cladribine treatment in patients with multiple sclerosis (P4.2-022). Neurology. 92(15_supplement).
13.
Mao, Zhifeng, César Álvarez-González, Christo Albor, et al.. (2018). Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?. Multiple Sclerosis Journal - Experimental Translational and Clinical. 4(2). 2453203735–2453203735. 7 indexed citations
14.
Mao, Zhifeng, César Álvarez-González, Özlem Kayım Yıldız, et al.. (2018). Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies. Multiple Sclerosis and Related Disorders. 27. 247–253. 9 indexed citations
15.
Mao, Zhifeng, César Álvarez-González, Benjamin Turner, et al.. (2018). Personalised dosing of cladribine for people with multiple sclerosis (P3.400). Neurology. 90(15_supplement).
16.
Álvarez-González, César, Joela Mathews, Sharmilee Gnanapavan, et al.. (2017). Treating multiple sclerosis with generic cladribine. Queen Mary Research Online (Queen Mary University of London). 1 indexed citations
17.
Álvarez-González, César, Ashok Adams, Joela Mathews, et al.. (2017). Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis. Annals of Clinical and Translational Neurology. 4(7). 506–511. 15 indexed citations
18.
Mao, Zhifeng, César Álvarez-González, Joela Mathews, et al.. (2017). PO134 Personalised dosing of cladribine to treat multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 88(Suppl 1). A47.4–A48. 2 indexed citations
19.
Álvarez-González, César, Joela Mathews, David Baker, et al.. (2016). TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE. Journal of Neurology Neurosurgery & Psychiatry. 87(12). e1.26–e1. 13 indexed citations
20.
Kabra, S. K., et al.. (2004). Can throat swab after physiotherapy replace sputum for identification of microbial pathogens in children with cystic fibrosis?. The Indian Journal of Pediatrics. 71(1). 21–23. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erin Coughlin Breakdown of academic impact, for papers by Gustavo Luna Breakdown of academic impact, for papers by Ian Gabriel Breakdown of academic impact, for papers by Teresa Olivé Breakdown of academic impact, for papers by Licínio Craveiro Breakdown of academic impact, for papers by Caroline Bensa Breakdown of academic impact, for papers by Nada Abou-Fayssal Breakdown of academic impact, for papers by Lawrence Kaplan Breakdown of academic impact, for papers by Maurice Dahdaleh Breakdown of academic impact, for papers by Adir Shaulov
Rankless by CCL
2026